The UK’s “most vulnerable” hospital patients, who are unable to build up an antibody response to Covid, are to be offered a new drug, Ronapreve.
It will be offered to those over-50 without the necessary antibodies, and those aged 12-49 who are immuno-compromised – for example those with certain cancers – who struggle to mount an antibody response, either through being exposed to Covid, or from vaccination.
The government said guidance would be sent to clinicians imminently so they can begin prescribing the treatment as soon as possible.
For more details please click on the link below:
